The study also shows that TPX2 plays a critical role in the progression and metastasis of colon cancer, which could be mechanistically associated with activity of MMP2 and finally, that TPX2 protein expression could serve as a novel biomarker to predict the risk of metastasis in colon carcinoma patients after a colectomy. This evidence concerns the gene MMP2 and colon carcinoma.